Beyond Air Inc (XAIR) - Total Liabilities
Based on the latest financial reports, Beyond Air Inc (XAIR) has total liabilities worth $28.49 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Beyond Air Inc (XAIR) cash flow conversion to assess how effectively this company generates cash.
Beyond Air Inc - Total Liabilities Trend (2014–2025)
This chart illustrates how Beyond Air Inc's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Beyond Air Inc's assets to evaluate the company's liquid asset resilience ratio.
Beyond Air Inc Competitors by Total Liabilities
The table below lists competitors of Beyond Air Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ArcWest Exploration Inc
V:AWX
|
Canada | CA$1.13 Million |
|
Locafy Ltd
NASDAQ:LCFY
|
USA | $2.00 Million |
|
Albion Resources Ltd
AU:ALB
|
Australia | AU$100.40K |
|
Cymat Technologies Ltd.
V:CYM
|
Canada | CA$7.50 Million |
|
Nippon Active Value Fund Plc
LSE:NAVF
|
UK | GBX4.13 Million |
|
Bio Green Med Solution, Inc.
NASDAQ:BGMS
|
USA | $1.34 Million |
|
Can Fite Biopharma Ltd
TA:CANF
|
Israel | ILA3.92 Million |
|
Gulf Resources, Inc. (NV) Common Stock
NASDAQ:GURE
|
USA | $24.45 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Beyond Air Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Beyond Air Inc.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.77 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beyond Air Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beyond Air Inc (2014–2025)
The table below shows the annual total liabilities of Beyond Air Inc from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $15.72 Million | -47.20% |
| 2024-03-31 | $29.77 Million | +11.43% |
| 2023-03-31 | $26.72 Million | +27.30% |
| 2022-03-31 | $20.99 Million | +108.61% |
| 2021-03-31 | $10.06 Million | +7.70% |
| 2020-03-31 | $9.34 Million | +72.90% |
| 2019-03-31 | $5.40 Million | -30.82% |
| 2018-03-31 | $7.81 Million | +25012.07% |
| 2017-03-31 | $31.10K | 0.00% |
| 2016-03-31 | $31.10K | -98.03% |
| 2015-03-31 | $1.58 Million | +271.29% |
| 2014-03-31 | $425.00K | -- |
About Beyond Air Inc
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treat… Read more